tiprankstipranks
Trending News
More News >
333D Limited (AU:T3D)
ASX:T3D
Australian Market

333D Limited (T3D) AI Stock Analysis

Compare
4 Followers

Top Page

AU:T3D

333D Limited

(Sydney:T3D)

Select Model
Select Model
Select Model
Neutral 44 (OpenAI - 5.2)
Rating:44Neutral
Price Target:
AU$0.04
▲(33.33% Upside)
The score is held down primarily by balance-sheet fragility (negative equity) and historically volatile profitability/cash flow, despite a clear FY2025 operating rebound. Technicals are mixed-to-weak with negative MACD and the price below key longer-term moving averages, and valuation is unattractive given the very high P/E and no dividend yield support.
Positive Factors
Revenue and profit rebound (FY2025)
A sizable revenue increase and return to ~14% net margin in FY2025 indicate the underlying business can scale to profitability. If sustained, this strengthens internal capital generation, supports reinvestment in growth initiatives, and reduces reliance on external funding over the medium term.
Low financial leverage
Zero reported debt across multiple years meaningfully lowers fixed financing obligations and interest risk. This structural flexibility gives management room to navigate earnings volatility, preserves operating cash for strategic uses, and reduces downside from credit market stress.
Positive operating and free cash flow in FY2025
Transitioning from multi-year cash burn to positive operating and free cash flow demonstrates improving operational efficiency and working-capital control. Durable cash generation is key to funding capex, R&D, or hiring without dilutive capital raises if the trend persists.
Negative Factors
Negative shareholders' equity
Persistent negative equity reflects accumulated losses and a thin capital base, constraining the company's ability to absorb future shocks. This structural solvency weakness raises the probability of needing new capital or dilutive financings, limiting long-term strategic optionality.
Multi-year profitability volatility
A history of volatile profits undermines predictability of earnings and makes long-term planning difficult. For investors and customers, inconsistent margins complicate capital allocation, hiring, and product investment decisions, and heightens execution risk over the medium term.
Inconsistent cash flow history
Irregular operating and free cash flows reduce the durability of the recent improvement; a small positive FCF (~$70.7k) provides limited buffer. Continued inconsistency elevates refinancing and liquidity risk and can constrain sustained investment in growth or margin expansion.

333D Limited (T3D) vs. iShares MSCI Australia ETF (EWA)

333D Limited Business Overview & Revenue Model

Company Description333D Limited, together with its subsidiaries, provides 3D printing services in Australia. The company offers 3D printing equipment and consumables; and sells 3D prints. 333D Limited was incorporated in 2006 and is based in Laverton North, Australia.
How the Company Makes Money333D Limited generates revenue primarily through the sale of 3D printed products and services. The company offers customized 3D printing solutions to various sectors, enabling clients to create prototypes, models, and finished goods. Additionally, 333D Limited may engage in partnerships with other businesses to expand its market reach and enhance its product offerings. The company could also explore opportunities in licensing its technology or collaborating on research and development initiatives to further drive its revenue streams. However, specific details about significant partnerships or additional revenue factors are currently unavailable.

333D Limited Financial Statement Overview

Summary
FY2025 shows a strong rebound (revenue up ~60%, return to positive net profit with ~14% margin, and positive operating/free cash flow), but the multi-year history of losses and volatility, combined with negative shareholders’ equity in FY2025, keeps financial risk elevated.
Income Statement
53
Neutral
The latest annual period (FY2025) shows a sharp rebound with revenue up ~60% and a return to positive net profit (~14% margin), supported by a healthier gross margin (~40%). However, profitability has been highly volatile: FY2020–FY2024 featured persistent losses and, in several years, deeply negative margins, which raises questions around earnings durability and the consistency of the underlying business model.
Balance Sheet
28
Negative
Leverage is currently low (total debt reported at zero in FY2022–FY2025), which reduces financial risk. The key weakness is solvency: shareholders’ equity is negative in FY2025 (and was materially negative across several prior years), implying accumulated losses and a thin capital base. Total assets increased in FY2025, but negative equity limits balance-sheet flexibility and can increase refinancing/raising-capital risk if performance weakens.
Cash Flow
41
Neutral
Cash generation improved in FY2025 with positive operating and free cash flow (~$70.7k), a meaningful step up from cash burn in FY2022–FY2024. That said, cash flow has been inconsistent year-to-year (including sizable outflows in FY2023 and FY2022), and FY2025 free cash flow declined versus the prior period on the provided growth metric. Overall, cash flow is improving but not yet stable enough to be viewed as structurally strong.
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue1.00M1.01M190.31K23.95K63.68K114.97K
Gross Profit396.34K403.08K181.29K-146.37K-209.88K-24.78K
EBITDA0.00144.81K-600.60K-836.10K-1.22M-488.88K
Net Income143.78K143.78K-506.61K-724.97K-1.24M-338.79K
Balance Sheet
Total Assets641.11K641.11K24.68K89.29K441.52K132.40K
Cash, Cash Equivalents and Short-Term Investments75.27K75.27K4.58K65.05K415.73K99.21K
Total Debt0.000.000.000.000.00300.00K
Total Liabilities686.08K686.08K553.85K505.88K365.68K678.88K
Stockholders Equity-44.96K-44.96K-529.17K-416.60K75.84K-546.47K
Cash Flow
Free Cash Flow70.68K70.68K-60.46K-350.69K-195.78K90.04K
Operating Cash Flow70.68K70.68K-60.46K-350.69K-195.78K90.04K
Investing Cash Flow0.000.000.000.000.000.00
Financing Cash Flow0.000.000.000.00512.30K0.00

333D Limited Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
61
Neutral
$37.18B12.37-10.20%1.83%8.50%-7.62%
61
Neutral
AU$4.42M1.10%34.27%
44
Neutral
AU$8.26M82.00426.44%
37
Underperform
AU$809.46K-0.17
* Technology Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
AU:T3D
333D Limited
0.04
0.03
192.86%
AU:1TT
Wooboard Technologies Limited
0.01
0.00
0.00%
AU:CT1
Constellation Technologies Limited

333D Limited Corporate Events

333D Flags Material Impairment in Bitcoin Treasury Holdings
Feb 2, 2026

333D Limited has reported that the market value of its Bitcoin treasury holdings stood at $228,838 as at 1 February 2026, representing an impairment of $141,661, or 13.6% of the consolidated group’s total assets, thereby triggering its continuous disclosure obligations under ASX Listing Rule 3.1. The company attributed the decline in the Australian dollar value of its Bitcoin position to a combination of cryptocurrency price volatility and a strengthening Australian dollar against the US dollar, and noted that it does not currently hedge its cryptocurrency or foreign exchange exposures, meaning investors should expect ongoing variability in reported valuations as part of its broader digital asset treasury strategy.

The most recent analyst rating on (AU:T3D) stock is a Hold with a A$0.04 price target. To see the full list of analyst forecasts on 333D Limited stock, see the AU:T3D Stock Forecast page.

333D posts sixth straight quarter of revenue growth and advances blockchain healthcare push
Jan 30, 2026

333D Limited reported its sixth consecutive quarter of growth in cash receipts, generating $330,917 from digital asset management contracts in the December quarter, reflecting a 3.92% increase and underscoring the success of its strategic pivot into healthcare-focused digital asset management. The company recorded net operating cash outflows of $99,180 on quarterly expenditure of about $430,097, ended the period with combined cash and Bitcoin holdings of $993,691, and highlighted progress in its BioScan 360 collaboration, having successfully stored full body MRI scan data on the blockchain with plans to scale this decentralised, patient-controlled data solution across the preventative healthcare market.

The most recent analyst rating on (AU:T3D) stock is a Hold with a A$0.05 price target. To see the full list of analyst forecasts on 333D Limited stock, see the AU:T3D Stock Forecast page.

333D Limited Announces Director’s Acquisition of Performance Rights
Dec 9, 2025

333D Limited has announced a change in the director’s interest, specifically involving Dr. Richard Petty, who has acquired 1,000,000 performance rights as part of the company’s Long Term Incentive Plan. This acquisition was made without cash consideration, indicating a strategic move to align the director’s interests with the company’s long-term goals, potentially impacting the company’s governance and stakeholder confidence.

333D Limited Updates Director’s Interest with New Incentives
Dec 9, 2025

333D Limited has announced a change in the director’s interest, specifically involving Dr. Nigel Finch. The change involves the acquisition of 750,000 performance rights by Saki Partners (Services) Pty Ltd, a company controlled by Dr. Finch, as part of the company’s Long Term Incentive Plan. This move increases the total performance rights held by Saki Partners to 2,250,000, reflecting the company’s strategy to incentivize its leadership.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jan 04, 2026